Abba Katharine, Gulani Anjana, Sachdev Harshpal S
International Health Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, UK, L3 5QA.
Cochrane Database Syst Rev. 2010 Feb 17(2):CD006639. doi: 10.1002/14651858.CD006639.pub2.
Otitis media (inflammation of the middle ear, usually caused by infection) affects people of all ages, but is particularly common in young children. Around 164 million people worldwide have long-term hearing loss caused by this condition, 90% of them in low-income countries. Because zinc supplements prevent pneumonia in disadvantaged children, we wondered whether they prevent otitis media.
To evaluate whether zinc supplements prevent otitis media in adults and children of different ages.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 2) which includes the Acute Respiratory Infection Groups' Specialised Register; MEDLINE (1950 to June Week 1 2009); and EMBASE (1974 to June 2009).
Randomised, placebo-controlled trials of zinc supplements given at least once a week for at least a month for preventing otitis media.
Two review authors assessed the eligibility and methodological quality of the included trials, extracted and analysed data and wrote the review. We summarised results using risk ratios or rate ratios for dichotomous data and mean differences for continuous data. We combined trial results where appropriate.
We identified 12 trials for inclusion, 10 of which contributed outcomes data. In trials of healthy children living in low-income communities, two trials did not demonstrate a significant difference between the zinc supplemented and placebo groups in the numbers of participants experiencing an episode of definite otitis media during follow up (3191 participants), while another trial showed a significantly lower incidence rate of otitis media in the zinc group (rate ratio 0.69, 95% confidence interval (CI) 0.61 to 0.79, n = 1621). A small trial of 39 infants undergoing treatment for severe malnutrition suggested a benefit of zinc on the mean number of episodes of otitis media (mean difference -1.12 episodes, 95% CI -2.21 to -0.03). Zinc supplements did not seem to cause any serious adverse events, but a small minority of children were reported to have vomited shortly after ingestion of the supplements.
AUTHORS' CONCLUSIONS: Evidence on whether zinc supplementation can reduce the incidence of otitis media in healthy children under the age of five years living in low- and middle-income countries is mixed. There is some evidence of benefit in children being treated for marasmus, but this is based on one small trial and should therefore be treated with caution.
中耳炎(中耳炎症,通常由感染引起)影响各年龄段人群,但在幼儿中尤为常见。全球约有1.64亿人因该病导致长期听力损失,其中90%在低收入国家。由于锌补充剂可预防弱势儿童患肺炎,我们想知道其是否能预防中耳炎。
评估锌补充剂能否预防不同年龄段成人和儿童患中耳炎。
我们检索了Cochrane对照试验中心注册库(CENTRAL)(《Cochrane图书馆》2009年第2期),其中包括急性呼吸道感染组的专业注册库;MEDLINE(1950年至2009年6月第1周);以及EMBASE(1974年至2009年6月)。
每周至少服用一次锌补充剂、持续至少一个月以预防中耳炎的随机、安慰剂对照试验。
两位综述作者评估了纳入试验的合格性和方法学质量,提取并分析数据,撰写综述。我们使用风险比或率比汇总二分数据的结果,使用均值差汇总连续数据的结果。在适当情况下合并试验结果。
我们确定了12项纳入试验,其中10项提供了结果数据。在低收入社区健康儿童的试验中,两项试验未显示补充锌组和安慰剂组在随访期间患明确中耳炎发作的参与者数量有显著差异(3191名参与者),而另一项试验显示锌组中耳炎发病率显著较低(率比0.69,95%置信区间(CI)0.61至0.79,n = 1621)。一项对39名接受重度营养不良治疗的婴儿进行的小型试验表明,锌对中耳炎发作的平均次数有益(均值差 -1.12次发作,95%CI -2.21至 -0.03)。锌补充剂似乎未引起任何严重不良事件,但据报道少数儿童在摄入补充剂后不久出现呕吐。
关于锌补充剂能否降低低收入和中等收入国家五岁以下健康儿童中耳炎发病率的证据不一。有一些证据表明对患消瘦症的儿童有益,但这基于一项小型试验,因此应谨慎对待。